Onyx in production deal with Xoma

XOMA will develop a large-scale process to manufacture ONXX's CI-1042 (ONYX-015) engineered adenovirus lacking the E1B 55-kDa gene that is in Phase III testing to treat head and neck cancer. ONXX said...